Your browser doesn't support javascript.
loading
The ion channel TRPM8 is a direct target of the immunosuppressant rapamycin in primary sensory neurons.
Arcas, José Miguel; Oudaha, Khalid; González, Alejandro; Fernández-Trillo, Jorge; Peralta, Francisco Andrés; Castro-Marsal, Júlia; Poyraz, Seyma; Taberner, Francisco; Sala, Salvador; de la Peña, Elvira; Gomis, Ana; Viana, Félix.
Afiliación
  • Arcas JM; Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, San Juan de Alicante, Spain.
  • Oudaha K; Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, San Juan de Alicante, Spain.
  • González A; Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, San Juan de Alicante, Spain.
  • Fernández-Trillo J; Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, San Juan de Alicante, Spain.
  • Peralta FA; Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, San Juan de Alicante, Spain.
  • Castro-Marsal J; Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, San Juan de Alicante, Spain.
  • Poyraz S; Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, San Juan de Alicante, Spain.
  • Taberner F; Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, San Juan de Alicante, Spain.
  • Sala S; Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, San Juan de Alicante, Spain.
  • de la Peña E; Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, San Juan de Alicante, Spain.
  • Gomis A; Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, San Juan de Alicante, Spain.
  • Viana F; Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, San Juan de Alicante, Spain.
Br J Pharmacol ; 181(17): 3192-3214, 2024 Sep.
Article en En | MEDLINE | ID: mdl-38741464
ABSTRACT
BACKGROUND AND

PURPOSE:

The mechanistic target of rapamycin (mTOR) signalling pathway is a key regulator of cell growth and metabolism. Its deregulation is implicated in several diseases. The macrolide rapamycin, a specific inhibitor of mTOR, has immunosuppressive, anti-inflammatory and antiproliferative properties. Recently, we identified tacrolimus, another macrolide immunosuppressant, as a novel activator of TRPM8 ion channels, involved in cold temperature sensing, thermoregulation, tearing and cold pain. We hypothesized that rapamycin may also have agonist activity on TRPM8 channels. EXPERIMENTAL

APPROACH:

Using calcium imaging and electrophysiology in transfected HEK293 cells and wildtype or Trpm8 KO mouse DRG neurons, we characterized rapamycin's effects on TRPM8 channels. We also examined the effects of rapamycin on tearing in mice. KEY

RESULTS:

Micromolar concentrations of rapamycin activated rat and mouse TRPM8 channels directly and potentiated cold-evoked responses, effects also observed in human TRPM8 channels. In cultured mouse DRG neurons, rapamycin increased intracellular calcium levels almost exclusively in cold-sensitive neurons. Responses were markedly decreased in Trpm8 KO mice or by TRPM8 channel antagonists. Cutaneous cold thermoreceptor endings were also activated by rapamycin. Topical application of rapamycin to the eye surface evokes tearing in mice by a TRPM8-dependent mechanism. CONCLUSION AND IMPLICATIONS These results identify TRPM8 cationic channels in sensory neurons as novel molecular targets of the immunosuppressant rapamycin. These findings may help explain some of its therapeutic effects after topical application to the skin and the eye surface. Moreover, rapamycin could be used as an experimental tool in the clinic to explore cold thermoreceptors.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Receptoras Sensoriales / Ratones Noqueados / Sirolimus / Canales Catiónicos TRPM / Inmunosupresores Límite: Animals / Humans / Male Idioma: En Revista: Br J Pharmacol Año: 2024 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Receptoras Sensoriales / Ratones Noqueados / Sirolimus / Canales Catiónicos TRPM / Inmunosupresores Límite: Animals / Humans / Male Idioma: En Revista: Br J Pharmacol Año: 2024 Tipo del documento: Article País de afiliación: España